drugset / Trial / NCT00044356
Phase II Trial of Allovectin-7® for Metastatic Melanoma
Parallel-groupOpen-labelTreatment
Summary
The purpose of this clinical trial is to determine if Allovectin-7®, an experimental gene-based immunotherapy, can shrink melanoma tumors. The trial will also examine if this treatment can improve the time to disease progression.
Timeline
- Start
- 2001-02
- Primary completion
- 2004-08
- Completion
- 2004-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allovectin-7® | Other / unclassified | — | Other |